Skip to content

Innospec IOSP Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value at other companies

CHE
ChemedCHE
85.8-25.1%
HTF
Heartflow, Inc. Common StockHTFL
15.9+124%
KEE
Keel Infrastructure Corp. Common StockKEEL
$0.72-35.7%
Belden logo
BeldenBDC
$39.44+80.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$1.08+4.9%
Boston Beer logo
Boston BeerSAM
$343.91-10.0%

Other financials

Income statement

See full
Revenue$453.2M+2.8%
Gross profit$123.5M-1.3%
Operating income$36.5M-14.1%
Net income$30.4M-7.3%
EPS (diluted)$1.22-6.9%

Balance sheet

See full
Cash & equivalents$289.1M-3.6%
Total debt$50.6M+14.0%
Total equity$1.3B+6.7%
Total assets$1.8B+2.5%

Cash flow

See full
Operating cash flow$17.6M-37.8%
CapEx$8.9M+6.0%
Free cash flow$8.7M-56.3%

Valuation

See full
Market cap$2.05B-23.6%

Profitability

See full
Gross margin27.4%-1.3pp
Operating margin6.9%-2.6pp
Net margin6.4%
FCF margin4.5%-1.1pp

Returns & leverage

See full
Return on equity8.8%
Debt / equity0.0×
Current ratio+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Innospec’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innospec's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innospec's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value?
Innospec (IOSP) reported share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value of $76.90 in Q1 2026.